최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of applied biological chemistry, v.64 no.2, 2021년, pp.185 - 192
김미란 (Department of Cosmetic Science, Semyung University) , 황형서 (Department of Cosmetic Science, Semyung University)
Psoriasis is a chronic intractable skin disease caused by various inflammatory cytokines such as IL-6, CXCL8, TNF-α, and IFN-γ, as well as IL-17A secreted from Th17 cells and is characterized by hyperkeratosis and chronic inflammation of the epidermis. Brazilin, an active ingredient of...
Sun S, Zhang X, Xu M, Zhang F, Tian. F, Cui. J, Xia Y, Liang C, Zhou Shujie, Wei H, Zhao Hui, Wu G, Xu Bohan, Liu X, Yang G, Wang Q, Zhang L, Gong Y, Shao C, Zou Y (2019) Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes. Cell Death Dis 10: 274
Roberson EDO, Bowcock AM (2010) Psoriasis genetics: breaking the barrier. Trends Genet 26: 415-423. doi: 10.1016/j.tig.2010.06.006
Langley RGB, Krueger GG, Griffiths CEM (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 64: ii18-ii23. doi: 10.1136/ard.2004.033217
Kimball AB, Gladman D, Gelfand JM, Gordon K, Horn EJ, Korman NJ, Korver G, Krueger GG, Strober BE, Lebwohl MG (2008) National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 58: 1031-1042. doi: 10.1016/j.jaad.2008.01.006
Vlachos C, Gaitanis G, Katsanos KH, Christodoulou DK, Tsianos E, Bassukas ID (2016) Psoriasis and inflammatory bowel disease: links and risks. Psoriasis (Auckl) 6: 73-92. doi: 10.2147/PTT.S85194
Oliveira MFSPD, Rocha BO, Duarte GV (2015) Psoriasis: classical and emerging comorbidities. An Bras Dermatol 90: 9-20. doi: 10.1590/abd1806-4841
Rendon A, Schakel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20: 1475. doi: 10.3390/ijms20061475
Christophers E (2001) Psoriasis-epidemiology and clinical spectrum. Clin Exp Dermatol 26: 314-320. doi: 10.1046/j.1365-2230.2001.00832.x
Alzahrani KS, Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, El-Sherbeeny AM, Alhoshani AR, Alshammari MA, Alotaibi MR, Al-Harbi MM (2019) Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis. Biomed Pharmacother 111: 347-358. doi: 10.1016/j.biopha.2018.12.060
Lowes MA, Suarez-Farinas M, Krueger JG (2014) Immunology of psoriasis. Ann Rev Immunol 32: 227-255. doi: 10.1146/annurevimmunol-032713-120225
Pirowska M, Obtulowicz A, Lipko-Godlewska S, Gozdzialska A, Podolec K, Wojas-Pelc A (2018) The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor α in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis. Postepy Dermatol Alergol 35: 360-366. doi: 10.5114/ada.2018.77665
Johansen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K (2009) Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol 160: 319-324. doi: 10.1111/j.1365-2133.2008.08902.x
McGeachy MJ, Cua DJ, Gaffen SL (2019) The IL-17 family of cytokines in health and disease. Immunity 50: 892-906. doi: 10.1016/j.immuni.2019.03.021
Brembilla NC, Senra L, Boehncke WH (2018) The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front Immunol 9: 1682. doi: 10.3389/fimmu.2018.01682
Furue K, Ito T, Tsuji G, Nakahara T, Furue M (2020) The CCL20 and CCR6 axis in psoriasis. Scandi J Immunol 91: e12846. doi: 10.1111/sji.12846
Bartlett HS, Million RP (2014) Targeting the IL-17-T H 17 pathway. Nat Rev Drug Discov 14: 11-12
Wu L, Chen X, Zhao J, Martin B, Zepp JA, Ko JS, Gu C, Cai G, Ouyang W, Sen G, Stark GR, Su B, Vines CM, Toumier C, Hamilton TA, Vidimos A, Gastman B, Liu C, Li X (2015) A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis. J Exp Med 212: 1571-1587. doi: 10.1084/jem.20150204
Chiricozzi A, Guttman-Yassky E, Suarez-Farinas M, Nograles KE, Tian S, Cardinale I, Chimenti S, Krueger JG (2011) Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131: 677-687. doi: 10.1038/jid.2010.340
Blauvelt A, Chiricozzi A (2018) The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clini Rev Allergy Immunol 55: 379-390
Calautti E, Avalle L, Poli V (2018) Psoriasis: a STAT3-centric view. Int J Mol Sci 19: 171. doi: 10.3390/ijms19010171
Li Q, Laumonnier Y, Syrovets T, Simmet T (2013) Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages. Acta Biochim Biophys Sin 45: 593-600. doi: 10.1093/abbs/gmt049
Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, Yamaguchi T, Nomura T, Ito H, Nakamura T, Sakaguchi N, Sakaguchi N (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204: 2803-2812. doi: 10.1084/jem.20071397
Liu Y, Lagowski JP, Gao S, Raymond JH, White CR, Kulesz-Martin MF (2010) Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes. J Invest Dermatol 130: 1384-1390. doi: 10.1038/jid.2009.416
Armstrong AW, Read C (2020) Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA 23: 1945-1960. doi:10.1001/jama.2020.4006
Mare SD, Jong ED, Van de Kerkhof PCM (1990) DNA content and Ks8. 12 binding of the psoriatic lesion during treatment with the vitamin D3 nalogue MC903 and betamethasone. Br J Dermatol 123: 291-295. doi: 10.1111/j.1365-2133.1990.tb06287.x
Ngamwonglumlert L, Devahastin S, Chiewchan N, Raghavan GV (2020) Color and molecular structure alterations of brazilein extracted from Caesalpinia sappan L. under different pH and heating conditions. Sci Rep 10: 1-10. doi: 10.1038/s41598-020-69189-3
Nirmal NP, Rajput MS, Prasad RG, Ahmad M (2015) Brazilin from Caesalpinia sappan heartwood and its pharmacological activities: A review. Asian Pac J Trop Med 8: 421-430. doi: 10.1016/j.apjtm.2015.05.014
Choi DH, Hwang HS (2019) Anti-inflammation activity of brazilin in TNF-α induced human psoriasis dermatitis skin model. Appl Biol Chem 62: 46. doi: 10.1186/s13765-019-0455-z
Arican O, Aral M, Sasmaz S, Ciragil P (2005) Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005: 273-279. doi: 10.1155/MI.2005.273
30Sano S (2015) Psoriasis as a barrier disease. Dermatologica Sinica 33: 64-69. doi: 10.1016/j.dsi.2015.04.010
Roberson ED, Bowcock AM (2010) Psoriasis genetics: breaking the barrier. Trends Genet 26: 415-423. doi: 10.1016/j.tig.2010.06.006
Toussirot E (2012) The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflammation & Allergy-Drug Targets 11: 159-168. doi: 10.2174/187152812800392805
Hawkes JE, Yan BY, Chan TC, Krueger JG (2018) Discovery of the IL23/IL-17 signaling pathway and the treatment of psoriasis. J Immunol 201: 1605-1613. doi: 10.4049/jimmunol.1800013
Xie J, Huang S, Huang H, Deng X, Yue P, Lin J, Yang M, Han L, Zhang DK (2021) Advances in the application of natural products and the novel drug delivery systems for psoriasis. Front Pharmacol 12: 644952. doi: 10.3389/fphar.2021.644952
Yuan H, Ma Q, Ye L, Piao G (2016) The traditional medicine and modern medicine form natural products. Molecules 21: 559. doi: 10.3390/molecules21050559
Shim JH (2019) Anti-inflammatory effect of brazilin in RAW264. 7 cells. Asian J Beauty Cosmetol 17: 107-115. doi: 10.20402/ajbc.2019.0270
※ AI-Helper는 부적절한 답변을 할 수 있습니다.